Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
Clinical trial NCT00059644 · TERMINATED
Trial details
- NCT number
- NCT00059644
- Sponsor
- Tanabe Pharma Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-07-01
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.